Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Psoriasis 1Polyps 1Osteoarthritis 1Leukemia, Myeloid, Chronic-Phase 1Hyperplasia 1Colorectal Neoplasms 1Cancer Cachexia 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Adenomatous Polyposis Coli 1

Interventions

Bevacizumab 112Fluorouracil 98Oxaliplatin 96Leucovorin 96Irinotecan 86Capecitabine 73Cetuximab 64Panitumumab 42pembrolizumab 38regorafenib 28Nivolumab 23IFL protocol 22Folfox protocol 21trifluridine tipiracil drug combination 14Radiotherapy 13durvalumab 11Gemcitabine 10Celecoxib 10tremelimumab 7binimetinib 7aflibercept 7Drug Therapy 7Disulfides 7Cyclophosphamide 7Trifluridine 6Trastuzumab 6Sunitinib 6Paclitaxel 6Immunoglobulin G 6Colonoscopy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Colorectal Neoplasms × Eicosapentaenoic Acid × Clear all
NCT01661764 2018-06-08

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

Vanderbilt University Medical Center

Phase 2 Completed
141 enrolled 16 charts
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡